Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
Protalix BioTherapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Protalix BioTherapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, four executives at Protalix BioTherapeutics received on average a compensation package of $782K, a 25% decrease compared to previous year.
Average pay of disclosed executives at Protalix BioTherapeutics
Dror Bashan, Chief Executive Officer, received $1.2M in total, which decreased by 14% compared to 2020. 51% of Bashan's compensation, or $585K, was in stock awards. Bashan also received $82K in option awards, $374K in salary, as well as $116K in other compensation.
Eyal Rubin, Chief Financial Officer, received a compensation package of $837K, which decreased by 9% compared to previous year. 46% of the compensation package, or $385K, was in stock awards.
Einat Brill Almon, Senior Vice President, Chief Development Officer, earned $628K in 2021, a 29% decrease compared to previous year.
Yaron Naos, Senior Vice President, Operations, received $505K in 2021.
Related executives
You may also like
Source: SEC filing on April 29, 2022.